Close window

chemagen is now part of Revvity
Visit Revvity.com to see our full portfolio

Close window

miRNA purification

Kits for miRNA purification from plasma

Kits for microRNA (miRNA) purification from plasma

The chemagic™ miRNA kits for purification of circulating cell-free small RNA from plasma are designed for the processing of 0.2  or 1 ml plasma with minimal hands-on time on the chemagic™ 360 instrument. The kits are designed for the use with plasma, serum or extracellular vesicles.

Medium volume cfDNA purification from plasma

Kit features

  • Designed for the use with the chemagic™ 360 instrument for miRNA purification in 24-well or 96-well format
  • Proprietary technology  based on the use of M-PVA Magnetic Beads for optimal nucleic acid yield and purity
  • Disposable plasticware included
  • Convenient packaging to reduce reagent waste
  • Reagents can be stored at room temperature
  • Consistent and scalable small RNA extraction with comparable yields to manual methods.
  • Suitable for various downstream assays and proven compatibility (refer App Note).

Please find below a selection of available kits for miRNA isolation from 0.2 or 1 ml plasma using  the chemagic™ 360 instrument.

chemagic miRNA Kits for automation

Catalog No.Kit NameInstrumentSamples/BatchPreps/KitSample VolumesProcessing Time
CMG-1224chemagic
miRNA 200 Kit H96
chemagic 360/MSM Iup to 969600.2 ml90 min
(incl. 10 min hands-on time)
CMG-1223chemagic
miRNA 1k Kit H24
chemagic 360/MSM Iup to 242401 ml90 min
(incl. 10 min hands-on time)

Download Manual

Catalog No.Kit NamePDF Protocol
CMG-1224chemagic™ miRNA 200 Kit H96Protocol CMG-1224 chemagic miRNA 200 Kit H96
CMG-1223chemagic™ miRNA 1k Kit H24Protocol CMG-1223 chemagic miRNA 1k Kit H24

Customer review

“We have started the testing of cfRNA isolations with our chemagic 360 instrument – the RNA yields appear fine from different plasma and serum samples, thus we look forward to use the kit for high throughput applications.”

Dr. Maija Puhka, Head of HiPrep and EV Core, Institute for Molecular Medicine Finland FIMM, University of Helsinki

Moon SM, Kim JH, Kim SK, Kim S, Kwon HJ, Bae JS, Lee S, Lee HS, Choi MY, Jeon BH, Jeong BH, Lee K, Kim HK, Kim J, Um SW. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer. Anticancer Res. 2020 Jun;40(6):3435-3444.

For research use only. Not for use in diagnostic procedures.

Please note that product labelling (such as kit insert, product label, and kit box) may be different compared to the company branding. Please contact your local representative for further details.